Condition

Basal Cell Carcinoma clinical trials and research

• 19Clinical trials
• 2NIH research projects
• 9Countries

Newest Basal Cell Carcinoma clinical trials

All recruiting trials (19)

• AI-based risk and subtype prediction for basal cell carcinoma using dermoscopic images

  A retrospective study tests an artificial intelligence model to classify basal cell carcinoma as low- or high-risk and to predict histopathological subtypes from archived dermoscopic images.

  Recruiting Istanbul Training and Research Hospital · Istanbul, Istanbul · NCT07677124

• Methionine-Reduced Diet in Solid Tumors (early-phase)

  A small pilot study will test whether a methionine-reduced diet can change blood levels in adults with various solid tumors who are receiving standard cancer therapy.

  Recruiting Early Phase 1 University of California, Irvine · Orange, California · NCT07628634

• In-home cancer treatment with remote specialist support for patients in the Florida Panhandle

  This program will try giving standard cancer treatments at home to people living in the Florida Panhandle and nearby areas to see if they prefer it and have better treatment satisfaction.

  Recruiting Phase 2 Mayo Clinic · Jacksonville, Florida · NCT07285044

• Vitamin D and light therapy to boost skin cancer response before surgery

  This study tests whether giving Vitamin D or a placebo around the time of a light-based treatment (PDT) can help boost skin cancer treatment before Mohs surgery or ED&C in adults with basal cell or squamous cell carcinoma.

  Recruiting Case Comprehensive Cancer Center · Cleveland, Ohio · NCT07241585

• Using line-field confocal OCT to map Mohs surgery margins for basal cell carcinoma

  This tests whether line-field confocal optical coherence tomography (LC-OCT) can noninvasively show the edges of basal cell carcinomas in adults scheduled for Mohs surgery.

  Recruiting Roswell Park Cancer Institute · Buffalo, New York · NCT07182240

• Neoadjuvant Opdualag (nivolumab + relatlimab) versus nivolumab for resectable high-risk basal cell carcinoma

  This trial tests whether adding relatlimab to nivolumab before surgery helps people with resectable high‑risk basal cell carcinoma shrink tumors and improve surgical outcomes.

  Recruiting at 3 sites Phase 2 University of California, San Diego · Irvine, California and 2 other locations · NCT06624475

• AI-assisted confocal imaging to guide removal of basal cell carcinoma

  This project tests whether an AI tool can analyze confocal microscope images during basal cell carcinoma surgery to give surgeons real-time guidance on which tissue to remove.

  Recruiting LMU Klinikum · Munich, Bavaria · NCT06600165

• Personalized immunotherapy platform for cancer treatment

  This study is testing a new way to identify melanoma and skin cancer patients who might not respond well to immunotherapy by analyzing their tumor samples.

  Recruiting at 3 sites Melanoma Institute Australia · Sydney, New South Wales and 2 other locations · NCT06536257

• Using advanced imaging to improve surgery for skin cancer

  This study is testing a new imaging technique to see if it can help doctors remove all of the skin cancer during surgery.

  Recruiting University of Rochester · Victor, New York · NCT06473103

• Using Raman Spectroscopy to assess skin cancer tumors

  This study is testing a new imaging technique to see if it can help doctors better understand the size and spread of skin cancer tumors in patients with basal cell and squamous cell carcinoma.

  Recruiting Stony Brook University · Stony Brook, New York · NCT06384924

• Adding water-filtered infrared-A heat to radiotherapy for non-melanoma skin cancer

  This trial tries adding water-filtered infrared-A (wIRA) heat to a lower-dose, accelerated radiotherapy schedule to see if it works as well as standard high-dose radiotherapy for people 65 or older with larger basal cell or squamous cell skin cancers.

  Recruiting at 4 sites Kantonsspital Winterthur KSW · Aarau, Canton of Aargau and 3 other locations · NCT06384053

• Evaluating SP-002 with Vismodegib for Advanced Basal Cell Carcinoma

  This study is testing if a new treatment called SP-002, when combined with the drug Vismodegib, can help people with advanced Basal Cell Carcinoma who can't have surgery.

  Recruiting at 10 sites Phase 2 Stamford Pharmaceuticals, Inc. · Phoenix, Arizona and 9 other locations · NCT06344052

• Observational study of patients with advanced basal cell carcinoma

  This study looks at patients with advanced basal cell carcinoma to better understand their characteristics, how the disease progresses, and what treatments are available.

  Recruiting Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse · Roma, ITA · NCT06309836

• MQ710 with or without pembrolizumab for advanced skin and other solid tumors

  This will test different doses of MQ710, alone or together with pembrolizumab, in adults with advanced or recurrent solid tumors (including skin cancers) to find a safe dose with mild side effects.

  Recruiting at 5 sites Phase 1 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT05859074

• Analyzing real-world treatment data for advanced skin cancer patients in Europe

  This study looks at real-world treatment experiences of people in Europe with advanced skin cancer to see how they are being treated and what outcomes they have.

  Recruiting EuMelaReg gGmbH · Brussels · NCT05741073

• Radiation after Sonic Hedgehog inhibitor response for locally advanced basal cell carcinoma

  This trial tests whether giving radiotherapy after a complete response to Sonic Hedgehog inhibitors (vismodegib or sonidegib) helps people with locally advanced basal cell carcinoma stay cancer-free.

  Recruiting Phase 2 University Hospital, Lille · Lille · NCT05561634

• Evaluating oral hedgehog inhibitors for treating basal cell carcinoma in the Netherlands

  This study is testing if two oral medications, vismodegib and sonidegib, can help people with advanced basal cell carcinoma or Gorlin syndrome feel better and improve their condition.

  Recruiting at 7 sites Maastricht University Medical Center · Nijmegen, Gelderland and 7 other locations · NCT05463757

• Imiquimod cream to help prevent facial basal cell carcinoma

  This trial tests whether applying imiquimod cream to the face for 12 weeks can prevent new basal cell carcinomas in high-risk Veterans over three years.

  Recruiting at 7 sites Phase 3 VA Office of Research and Development · Long Beach, California and 7 other locations · NCT05212246

• Nivolumab treatment for advanced basal cell carcinoma

  This study is testing if the drug nivolumab, alone or with other medications, can help people with advanced basal cell carcinoma that can't be removed by surgery.

  Recruiting Phase 2 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Baltimore, Maryland · NCT03521830

NIH-funded research (2)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• How the skin tumor environment drives basal cell carcinoma growth and resistance

  Testing ways to stop basal cell skin cancers from changing into more treatment‑resistant forms by targeting the tumor environment and key gene switches for people with BCC.

  NIH research Stanford University · Stanford, United States · NIH-11307134

• Creating better models to understand how basal cell carcinoma responds to treatment

  This study is working on better ways to understand and treat basal cell carcinoma, the most common skin cancer, by testing how tumors in mice respond to treatments, which could help find more effective options for patients like you.

  NIH research University of Michigan at Ann Arbor · Ann Arbor, United States · NIH-10518702

Related topics

Quick answers

How many Basal Cell Carcinoma clinical trials are recruiting right now?

19, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 9 countries. The most sites are in United States (11 trials), Australia (1 trial), France (1 trial), Germany (1 trial), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 3: 1, Early Phase 1: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →